Neuberger Berman Group’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
33,590
+3,847
| +13% | +$139K | ﹤0.01% | 1291 |
|
|
2025
Q1 | $926K | Buy |
29,743
+13,249
| +80% | +$412K | ﹤0.01% | 1342 |
|
|
2024
Q4 | $421K | Buy |
16,494
+1,882
| +13% | +$48K | ﹤0.01% | 1565 |
|
|
2024
Q3 | $413K | Buy |
14,612
+6,839
| +88% | +$193K | ﹤0.01% | 1569 |
|
|
2024
Q2 | $205K | Sell |
7,773
-13,563
| -64% | -$358K | ﹤0.01% | 1755 |
|
|
2024
Q1 | $648K | Buy |
21,336
+2,194
| +11% | +$66.6K | ﹤0.01% | 1412 |
|
|
2023
Q4 | $538K | Sell |
19,142
-511,692
| -96% | -$14.4M | ﹤0.01% | 1462 |
|
|
2023
Q3 | $14.4M | Buy |
530,834
+1,881
| +0.4% | +$51.1K | 0.01% | 665 |
|
|
2023
Q2 | $16.3M | Sell |
528,953
-7,014
| -1% | -$216K | 0.01% | 647 |
|
|
2023
Q1 | $19.3M | Sell |
535,967
-7,494
| -1% | -$270K | 0.02% | 632 |
|
|
2022
Q4 | $21.5M | Buy |
543,461
+4,318
| +0.8% | +$171K | 0.02% | 598 |
|
|
2022
Q3 | $21.7M | Buy |
539,143
+109
| +0% | +$4.38K | 0.02% | 594 |
|
|
2022
Q2 | $22.7M | Buy |
539,034
+154,190
| +40% | +$6.48M | 0.02% | 597 |
|
|
2022
Q1 | $15M | Buy |
+384,844
| New | +$15M | 0.01% | 730 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$486K | – | 1650 |
|
|
2020
Q2 | $486K | Buy |
+10,000
| New | +$486K | ﹤0.01% | 1283 |
|